Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration

AL Misko, Y Sasaki, E Tuck, J Milbrandt… - Journal of …, 2012 - Soc Neuroscience
Alterations in mitochondrial dynamics (fission, fusion, and movement) are implicated in
many neurodegenerative diseases, from rare genetic disorders such as Charcot-Marie-Tooth …

Delineating the phenotypic spectrum of sulfite oxidase and molybdenum cofactor deficiency

AL Misko, Y Liang, JB Kohl, F Eichler - Neurology: Genetics, 2020 - AAN Enterprises
Objective To define the phenotypic spectrum of isolated sulfite oxidase (ISOD) and molybdenum
cofactor deficiency (MoCD), aiming to promote timely diagnosis and assist in future …

[HTML][HTML] Progress in elucidating pathophysiology of mucolipidosis IV

A Misko, L Wood, K Kiselyov, S Slaugenhaupt… - Neuroscience …, 2021 - Elsevier
Mucolipidosis IV (MLIV) is an autosomal-recessive disease caused by loss-of-function mutations
in the MCOLN1 gene encoding the non-selective cationic lysosomal channel transient …

Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex

A Misko, S Jiang, I Wegorzewska… - Journal of …, 2010 - Soc Neuroscience
Mitofusins (Mfn1 and Mfn2) are outer mitochondrial membrane proteins involved in
regulating mitochondrial dynamics. Mutations in Mfn2 cause Charcot-Marie-Tooth disease (CMT) …

Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV

…, SA Slaugenhaupt, A Misko… - Disease models & …, 2020 - journals.biologists.com
Mucolipidosis type IV (MLIV) is a lysosomal disease caused by mutations in the MCOLN1
gene that encodes the endolysosomal transient receptor potential channel mucolipin-1, or …

[HTML][HTML] The role of glutamate oxaloacetate transaminases in sulfite biosynthesis and H2S metabolism

AT Mellis, AL Misko, S Arjune, Y Liang, K Erdélyi… - Redox Biology, 2021 - Elsevier
Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency are two rare genetic
disorders that are caused by impairment of the mitochondrial enzyme sulfite oxidase. Sulfite …

MCOLN1 gene therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV

…, S Slaugenhaupt, A Misko… - Human Molecular …, 2021 - academic.oup.com
Mucolipidosis IV (MLIV) is an orphan disease leading to debilitating psychomotor deficits
and vision loss. It is caused by loss-of-function mutations in the MCOLN1 gene that encodes …

[HTML][HTML] Sulfite alters the mitochondrial network in molybdenum cofactor deficiency

AT Mellis, J Roeper, AL Misko, J Kohl… - Frontiers in …, 2021 - frontiersin.org
Molybdenum cofactor deficiency (MoCD) is an autosomal recessive disorder belonging to the
large family of inborn errors in metabolism. Patients typically present with encephalopathy …

White matter abnormalities and iron deposition in prenatal mucolipidosis IV-fetal imaging and pathology

…, Y Fisher, R Schiffmann, Y Grishchuk, AL Misko… - Metabolic Brain …, 2021 - Springer
Mucolipidosis type IV (MLIV; OMIM 252,650) is an autosomal recessive lysosomal disorder
caused by mutations in MCOLN1. MLIV causes psychomotor impairment and progressive …

Cross-sectional Observations on the Natural History of Mucolipidosis Type IV

AL Misko, LB Wood, M DeBono, R Oberman… - Neurology …, 2022 - AAN Enterprises
Background and Objectives Mucolipidosis type IV (MLIV) is an ultra-rare lysosomal disorder
initially described as a static neurodevelopmental condition. However, patient caregivers …